{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:49:25Z","timestamp":1777625365028,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA028957"],"award-info":[{"award-number":["AA028957"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["11,542,227 B2"],"award-info":[{"award-number":["11,542,227 B2"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpet.2025.103748","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:12:52Z","timestamp":1760145172000},"page":"103748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular mechanisms of 10-butyl ether minocycline, a novel nonantibiotic tetracycline, as a potential treatment for inflammatory and neuroimmune-related disorders"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7269-075X","authenticated-orcid":false,"given":"Abdul A.","family":"Shaik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5884-5892","authenticated-orcid":false,"given":"Praneetha","family":"Panthagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-4537","authenticated-orcid":false,"given":"Xiaobo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-9061","authenticated-orcid":false,"given":"Stephany","family":"Navarro-Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9491-2960","authenticated-orcid":false,"given":"Jeremy","family":"Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7193-7827","authenticated-orcid":false,"given":"Abdul","family":"Hamood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted W.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-0896","authenticated-orcid":false,"given":"Bruce","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4475-7502","authenticated-orcid":false,"given":"Elliott","family":"Pauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3767-2922","authenticated-orcid":false,"given":"Jeremy D.","family":"Bailoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-8954","authenticated-orcid":false,"given":"Susan E.","family":"Bergeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000017847","article-title":"Systemic antibiotics for acne","volume":"196","author":"Meynadier","year":"1998","journal-title":"Dermatology"},{"issue":"2 Pt 1","key":"10.1016\/j.jpet.2025.103748_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0190-9622(95)90130-2","article-title":"Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans","volume":"32","author":"Nowakowski","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpet.2025.103748_bib4","first-page":"190","article-title":"Tetracycline therapy in chronic urinary tract infection","volume":"8","author":"Anderson","year":"1966","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"Microbiologyopen"},{"issue":"7","key":"10.1016\/j.jpet.2025.103748_bib6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","article-title":"The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit","volume":"103","author":"Brodersen","year":"2000","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.jpet.2025.103748_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh0066","article-title":"Multiple approaches of cellular metabolism define the bacterial ancestry of mitochondria","volume":"9","author":"Geiger","year":"2023","journal-title":"Sci Adv"},{"issue":"10","key":"10.1016\/j.jpet.2025.103748_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.celrep.2015.02.034","article-title":"Tetracyclines disturb mitochondrial function across eukaryotic models: a call for caution in biomedical research","volume":"10","author":"Moullan","year":"2015","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.chembiol.2018.09.010","article-title":"Tetracyclines modify translation by targeting key human rRNA substructures","volume":"25","author":"Mortison","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103748_bib10","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.4110\/in.2020.20.e47","article-title":"Immunotherapy of autoimmune diseases with nonantibiotic properties of tetracyclines","volume":"20","author":"Park","year":"2020","journal-title":"Immune Netw"},{"key":"10.1016\/j.jpet.2025.103748_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jgar.2020.01.022","article-title":"Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future","volume":"22","author":"Asadi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jpet.2025.103748_bib12","series-title":"Drug Repurposing for Emerging Infectious Diseases and Cancer","article-title":"Repurposing of minocycline, a tetracycline antibiotic, for neurodegene","author":"Sanshita","year":"2023"},{"issue":"7","key":"10.1016\/j.jpet.2025.103748_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/biom14070783","article-title":"Third-generation tetracyclines: current knowledge and therapeutic potential","volume":"14","author":"Kounatidis","year":"2024","journal-title":"Biomolecules"},{"issue":"5-6","key":"10.1016\/j.jpet.2025.103748_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00702-021-02457-2","article-title":"Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease","volume":"129","author":"Markulin","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00210-021-02188-x","article-title":"Metalloproteinases and their inhibitors in neurological disease","volume":"395","author":"Lopez-Navarro","year":"2022","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jpet.2025.103748_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106237","article-title":"The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems","volume":"175","author":"Rahmani","year":"2022","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12868-024-00851-6","article-title":"Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models","volume":"25","author":"Ritter","year":"2024","journal-title":"BMC Neurosci"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1592\/phco.26.4.515","article-title":"Minocycline for acute neuroprotection","volume":"26","author":"Elewa","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Garrido-Mesa","year":"2013","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11481-021-09986-3","article-title":"Repurposing of tetracyclines for COVID-19 neurological and neuropsychiatric manifestations: a valid option to control SARS-CoV-2-associated neuroinflammation?","volume":"16","author":"Chaves Filho","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/13543784.2022.2054325","article-title":"Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications","volume":"31","author":"Garrido-Mesa","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jpainsymman.2020.01.007","article-title":"A randomized, placebo-controlled, double-blind study of minocycline for reducing the symptom burden experienced by patients with advanced pancreatic cancer","volume":"59","author":"Kamal","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpet.2025.103748_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.901911","article-title":"Profiling the effects of systemic antibiotics for acne, including the narrow-spectrum antibiotic sarecycline, on the human gut microbiota","volume":"13","author":"Moura","year":"2022","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/neu.2009.1223","article-title":"Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study","volume":"27","author":"Homsi","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jpet.2025.103748_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fpsyt.2018.00558","article-title":"Minocycline attenuates stress-induced behavioral changes via its anti-inflammatory effects in an animal model of post-traumatic stress disorder","volume":"9","author":"Wang","year":"2018","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12974-018-1379-y","article-title":"Early treatment with minocycline following stroke in rats improves functional recovery and differentially modifies responses of peri-infarct microglia and astrocytes","volume":"16","author":"Yew","year":"2019","journal-title":"J Neuroinflam"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib27","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3390\/biomedicines10123222","article-title":"Minocycline inhibits microglial activation and improves visual function in a chronic model of age-related retinal degeneration","volume":"10","author":"Du","year":"2022","journal-title":"Biomedicines"},{"issue":"26","key":"10.1016\/j.jpet.2025.103748_bib28","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","article-title":"Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia","volume":"95","author":"Yrj\u00e4nheikki","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-5-15","article-title":"Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia","volume":"5","author":"Henry","year":"2008","journal-title":"J Neuroinflamm"},{"issue":"21","key":"10.1016\/j.jpet.2025.103748_bib30","article-title":"Minocycline attenuates lipopolysaccharide-induced locomotor deficit and anxiety-like behavior and related expression of the BDNF\/CREB protein in the rat medial prefrontal cortex (mPFC)","volume":"23","author":"Qaid","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jpet.2025.103748_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1745-7254.2007.00578.x","article-title":"Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats","volume":"28","author":"Chu","year":"2007","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.RES.0000138581.04174.2f","article-title":"Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor\u2013induced smooth muscle cell migration","volume":"95","author":"Yao","year":"2004","journal-title":"Circ Res"},{"issue":"S1","key":"10.1016\/j.jpet.2025.103748_bib33","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2018.32.1_supplement.676.3","article-title":"Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration via induction of RECK","volume":"32","author":"Higashi","year":"2018","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jpet.2025.103748_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.neuint.2006.10.008","article-title":"Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration","volume":"50","author":"Yao","year":"2006","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.jpet.2025.103748_bib35","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1161\/STROKEAHA.111.618215","article-title":"Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke","volume":"42","author":"Switzer","year":"2011","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.jpet.2025.103748_bib36","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ene.13403","article-title":"Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study","volume":"24","author":"Chang","year":"2017","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174853","article-title":"Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: a comparative study","volume":"12","author":"Vandooren","year":"2017","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acn3.492","article-title":"Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition","volume":"4","author":"Vellimana","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2202-7-56","article-title":"Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke","volume":"7","author":"Machado","year":"2006","journal-title":"BMC Neurosci"},{"issue":"7","key":"10.1016\/j.jpet.2025.103748_bib40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1902\/jop.2002.73.7.726","article-title":"Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines","volume":"73","author":"Ramamurthy","year":"2002","journal-title":"J Periodontol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103748_bib41","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1161\/STROKEAHA.106.481515","article-title":"Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage","volume":"38","author":"Lee","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib42","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/ijms22041642","article-title":"Minocycline impact on redox homeostasis of normal human melanocytes HEMn-LP exposed to UVA radiation and hydrogen peroxide","volume":"22","author":"Rok","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jpet.2025.103748_bib43","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.3390\/ijms22073755","article-title":"Molecular and biochemical basis of minocycline-induced hyperpigmentation\u2014the study on normal human melanocytes exposed to UVA and UVB radiation","volume":"22","author":"Jakub","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103748_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","article-title":"Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity","volume":"94","author":"Kraus","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpet.2025.103748_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2018.08.015","article-title":"Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation","volume":"143","author":"Liu","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jpet.2025.103748_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2019.01.045","article-title":"Minocycline ameliorates anxiety-related self-grooming behaviors and alters hippocampal neuroinflammation, GABA and serum cholesterol levels in female Sprague-Dawley rats subjected to chronic unpredictable mild stress","volume":"363","author":"Zhang","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jpet.2025.103748_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2019.11.009","article-title":"Minocycline treatment prevents depression and anxiety-like behaviors and promotes neuroprotection after experimental ischemic stroke","volume":"155","author":"Camargos","year":"2020","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FBP.0000000000000754","article-title":"Minocycline as a potential anxiolytic drug: systematic review and meta-analysis of evidence in murine models","volume":"35","author":"Iglesias","year":"2024","journal-title":"Behav Pharmacol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103748_bib49","article-title":"Evaluation of antidepressant effect of minocycline in alcohol abstinence-induced depression model in mice","volume":"14","author":"Gajbhiye","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-020-00948-6","article-title":"Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial","volume":"46","author":"Nettis","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2025.103748_bib51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2017.12.067","article-title":"A pilot study of minocycline for the treatment of bipolar depression: effects on cortical glutathione and oxidative stress in vivo","volume":"230","author":"Murrough","year":"2018","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pbb.2012.01.005","article-title":"The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice","volume":"101","author":"Fujita","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jpet.2025.103748_bib53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pnpbp.2014.04.008","article-title":"Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat","volume":"53","author":"Attarzadeh-Yazdi","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib54","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1080\/01480545.2021.1942484","article-title":"The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice","volume":"45","author":"Ghavimi","year":"2022","journal-title":"Drug Chem Toxicol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib55","doi-asserted-by":"crossref","first-page":"559.e1","DOI":"10.1016\/j.genhosppsych.2009.12.005","article-title":"A case of methamphetamine use disorder treated with the antibiotic drug minocycline","volume":"32","author":"Tanibuchi","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/WNF.0000000000000460","article-title":"Successful use of minocycline for the treatment of methamphetamine-induced psychosis and cognitive impairments: an open-label case series","volume":"44","author":"Alavi","year":"2021","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1369-1600.2010.00284.x","article-title":"Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies","volume":"17","author":"Blednov","year":"2011","journal-title":"Addict Biol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103748_bib58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1601-183X.2008.00405.x","article-title":"Alcohol trait and transcriptional genomic analysis of C57BL\/6 substrains","volume":"7","author":"Mulligan","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.jpet.2025.103748_bib59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuropharm.2017.10.035","article-title":"Microglial-specific transcriptome changes following chronic alcohol consumption","volume":"128","author":"McCarthy","year":"2017","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.jpet.2025.103748_bib60","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1073\/pnas.0510188103","article-title":"Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis","volume":"103","author":"Mulligan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acer.12288","article-title":"Bioinformatics analyses reveal age-specific neuroimmune modulation as a target for treatment of high ethanol drinking","volume":"38","author":"Agrawal","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2025.103748_bib62","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.bbi.2011.03.002","article-title":"Minocycline reduces ethanol drinking","volume":"25","author":"Agrawal","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpet.2025.103748_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2018.12.007","article-title":"Neuroimmune signaling in alcohol use disorder","volume":"177","author":"Erickson","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pmic.201000273","article-title":"Proteomic analysis of the anti-inflammatory action of minocycline","volume":"11","author":"Dunston","year":"2010","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-021-02123-0","article-title":"Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota","volume":"18","author":"Schmidt","year":"2021","journal-title":"J Neuroinflamm"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib66","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archneurol.2010.191","article-title":"Prospects for minocycline neuroprotection","volume":"67","author":"Plane","year":"2010","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib67","article-title":"Minocycline and magnesium as neuroprotective agents for ischemic stroke: a systematic review","volume":"12","author":"Ortiz","year":"2020","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.jpet.2025.103748_bib68","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.imbio.2009.12.003","article-title":"Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection","volume":"215","author":"Dutta","year":"2010","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2010.12.011","article-title":"The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties","volume":"63","author":"Garrido-Mesa","year":"2011","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1574884713666180228110310","article-title":"Minocycline in alcohol withdrawal induced anxiety and alcohol relapse in rats","volume":"13","author":"Gajbhiye","year":"2018","journal-title":"Curr Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12715","article-title":"The role of matrix metalloproteinase-9 in negative reinforcement learning and plasticity in alcohol dependence","volume":"25","author":"Go","year":"2019","journal-title":"Addict Biol"},{"issue":"8","key":"10.1016\/j.jpet.2025.103748_bib72","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s11064-020-03053-8","article-title":"Matrix metalloproteinase-9 overexpression regulates hippocampal synaptic plasticity and decreases alcohol consumption and preference in mice","volume":"45","author":"Yin","year":"2020","journal-title":"Neurochem Res"},{"issue":"45","key":"10.1016\/j.jpet.2025.103748_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado5820","article-title":"Polygenic risk for alcohol use disorder affects cellular responses to ethanol exposure in a human microglial cell model","volume":"10","author":"Li","year":"2024","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13374","article-title":"Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol","volume":"29","author":"Rasool","year":"2024","journal-title":"Addict Biol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib75","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.biopsych.2020.08.025","article-title":"New microglial mechanisms revealed in alcohol use disorder: how does that translate?","volume":"88","author":"Portis","year":"2020","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib76","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/acer.13259","article-title":"Effective reduction of acute ethanol withdrawal by the tetracycline derivative, tigecycline, in female and male DBA\/2J mice","volume":"40","author":"Martinez","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib77","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1111\/acer.13253","article-title":"Effective reduction in high ethanol drinking by semisynthetic tetracycline derivatives","volume":"40","author":"Syapin","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib78","article-title":"Minocycline-induced disruption of the intestinal FXR\/FGF15 axis impairs osteogenesis in mice","volume":"8","author":"Matthew","year":"2023","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.jpet.2025.103748_bib79","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/AAC.04895-14","article-title":"Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome","volume":"59","author":"Schedlbauer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/07347324.2024.2406551","article-title":"10-Butyl ether minocycline reduced high alcohol consumption in a dependence mouse model","volume":"43","author":"Panthagani","year":"2024","journal-title":"Alcohol Treat Quart"},{"key":"10.1016\/j.jpet.2025.103748_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2024.1357363","article-title":"The Horizontal Ladder Test (HLT) protocol: a novel, optimized, and reliable means of assessing motor coordination in Sus scrofa domesticus","volume":"18","author":"Liu","year":"2024","journal-title":"Front Behav Neurosci"},{"issue":"S1","key":"10.1016\/j.jpet.2025.103748_bib82","first-page":"150","article-title":"An initial validation of a DSM-V based porcine model of alcohol use disorder","volume":"47","author":"Liu","year":"2023","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.jpet.2025.103748_bib83","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/07347324.2024.2355931","article-title":"A pilot study: treatment of high alcohol consumption in a novel minipig model of alcohol use disorder","volume":"42","author":"Liu","year":"2024","journal-title":"Alcohol Treat Q"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.12.12.10","article-title":"Minocycline and diacetyl minocycline eye drops reduce ocular neovascularization in mice","volume":"12","author":"Willms","year":"2023","journal-title":"Transl Vision Sci Technol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Methods for in vitro evaluating antimicrobial activity: a review","volume":"6","author":"Balouiri","year":"2015","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.jpet.2025.103748_bib86","article-title":"Aseptic laboratory techniques: plating methods","volume":"63","author":"Sanders","year":"2012","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib87","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.patbio.2010.07.020","article-title":"Comparison of the Sensititre YeastOne(R) dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains","volume":"59","author":"Bertout","year":"2011","journal-title":"Pathol Biol (Paris)"},{"issue":"Suppl 19","key":"10.1016\/j.jpet.2025.103748_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0036-46652015000700011","article-title":"Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology","volume":"57","author":"Alastruey-Izquierdo","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"7","key":"10.1016\/j.jpet.2025.103748_bib89","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"7","key":"10.1016\/j.jpet.2025.103748_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102227","article-title":"Attenuation of reactive oxygen species (ROS) generation in the cultured retinal cells under high glucose conditions","volume":"34","author":"Ola","year":"2022","journal-title":"J King Saud Univ Sci"},{"issue":"8","key":"10.1016\/j.jpet.2025.103748_bib91","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","article-title":"Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia","volume":"21","author":"Tikka","year":"2001","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib92","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12885-024-12064-5","article-title":"Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells","volume":"24","author":"Mathur","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpet.2025.103748_bib93","article-title":"General Chapters\u2014Packaging and Distribution. Packaging and Storage Requirements","year":"2017","journal-title":"USP"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics1010001","article-title":"Classification framework and chemical biology of tetracycline-structure-based drugs","volume":"1","author":"Fuoco","year":"2012","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jpet.2025.103748_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1208974","article-title":"Dynamic regulation of the extracellular matrix in reward memory processes: a question of time","volume":"17","author":"Valeri","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jpet.2025.103748_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114330","article-title":"Matrix metalloproteinase-9 overexpression in the hippocampus reduces alcohol-induced conditioned-place preference by regulating synaptic plasticity in mice","volume":"442","author":"Yin","year":"2023","journal-title":"Behav Brain Res"},{"issue":"16","key":"10.1016\/j.jpet.2025.103748_bib97","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00018-019-03180-8","article-title":"MMPs in learning and memory and neuropsychiatric disorders","volume":"76","author":"Beroun","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"45","key":"10.1016\/j.jpet.2025.103748_bib98","doi-asserted-by":"crossref","first-page":"78677","DOI":"10.18632\/oncotarget.20207","article-title":"Regulation of neuroinflammation by matrix metalloproteinase-8 inhibitor derivatives in activated microglia and astrocytes","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpet.2025.103748_bib99","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ccr.2016.04.009","article-title":"Impact of metal coordination on the antibiotic and non-antibiotic activities of tetracycline-based drugs","volume":"327-328","author":"Guerra","year":"2016","journal-title":"Coord Chem Rev"},{"issue":"6","key":"10.1016\/j.jpet.2025.103748_bib100","first-page":"1204","article-title":"Microglial depletion and repopulation: a new era of regenerative medicine?","volume":"16","author":"Barnett","year":"2020","journal-title":"Neural Regen Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib101","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopsych.2020.05.011","article-title":"Microglia control escalation of drinking in alcohol dependent mice: genomic and synaptic drivers","volume":"88","author":"Warden","year":"2020","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11481-025-10173-x","article-title":"Pharmacological depletion of microglia protects against alcohol-induced corticolimbic neurodegeneration during intoxication in male rats","volume":"20","author":"Carlson","year":"2025","journal-title":"J Neuroimmune Pharmacol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib103","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/acer.13511","article-title":"Alcohol and stress activation of microglia and neurons: brain regional effects","volume":"41","author":"Walter","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib104","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1038\/s41598-023-32798-9","article-title":"LPS induces microglial activation and GABAergic synaptic deficits in the hippocampus accompanied by prolonged cognitive impairment","volume":"13","author":"Jung","year":"2023","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jpet.2025.103748_bib105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2003.11.007","article-title":"Neurobiological mechanisms in the transition from drug use to drug dependence","volume":"27","author":"Koob","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jpet.2025.103748_bib106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-28720-6_129","article-title":"Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder","volume":"13","author":"Koob","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"issue":"10","key":"10.1016\/j.jpet.2025.103748_bib107","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s11756-022-01162-z","article-title":"Hypothesized neuroprotective effect of minocycline against COVID-19-induced stroke and neurological dysfunction: possible role of matrix metalloprotease signaling pathway","volume":"77","author":"Aghajani Shahrivar","year":"2022","journal-title":"Biologia (Bratisl)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103748_bib108","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/nep3.46","article-title":"Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection","volume":"2","author":"Roman","year":"2024","journal-title":"Neuroprotection"},{"key":"10.1016\/j.jpet.2025.103748_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109569","article-title":"GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders","volume":"235","author":"Nicoletti","year":"2023","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.jpet.2025.103748_bib110","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.3390\/ijms25126521","article-title":"Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders","volume":"25","author":"Nicosia","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.jpet.2025.103748_bib111","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1007\/s11064-022-03645-6","article-title":"Lipoxygenase metabolism: critical pathways in microglia-mediated neuroinflammation and neurodevelopmental disorders","volume":"47","author":"Chen","year":"2022","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.jpet.2025.103748_bib113","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/0008-5472.CAN-15-1626","article-title":"Tetracycline antibiotics impair mitochondrial function and its experimental use confounds research","volume":"75","author":"Chatzispyrou","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib114","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.immuni.2020.09.011","article-title":"Tetracycline antibiotics induce host-dependent disease tolerance to infection","volume":"54","author":"Colaco","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jpet.2025.103748_bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-022-03909-1","article-title":"Immunomodulation by tetracyclines in the critically ill: an emerging treatment option?","volume":"26","author":"Sauer","year":"2022","journal-title":"Crit Care"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:01:21Z","timestamp":1777420881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022356525402614"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103748","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms of 10-butyl ether minocycline, a novel nonantibiotic tetracycline, as a potential treatment for inflammatory and neuroimmune-related disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103748"}}